|
ZNF35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.036000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.360300E-02 |
| Normal-vs-Stage2 |
5.515900E-03 |
| Normal-vs-Stage3 |
8.445500E-04 |
| Normal-vs-Stage4 |
5.027200E-04 |
| Stage1-vs-Stage2 |
1.193770E-01 |
| Stage1-vs-Stage3 |
3.950500E-02 |
| Stage1-vs-Stage4 |
5.328100E-02 |
| Stage2-vs-Stage3 |
8.329400E-01 |
| Stage2-vs-Stage4 |
4.815200E-01 |
| Stage3-vs-Stage4 |
5.782000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.399200E-03 |
| Normal-vs-AfricanAmerican |
5.286400E-02 |
| Normal-vs-Asian |
2.054400E-02 |
| Caucasian-vs-AfricanAmerican |
4.786200E-01 |
| Caucasian-vs-Asian |
5.441000E-01 |
| AfricanAmerican-vs-Asian |
3.325400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.989620E-04 |
| Normal-vs-Female |
4.980600E-01 |
| Male-vs-Female |
3.215400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.876400E-02 |
| Normal-vs-Extreme_Weight |
6.758200E-04 |
| Normal-vs-Obese |
8.140200E-03 |
| Normal-vs-Extreme_Obese |
2.868300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.861400E-01 |
| Normal_Weight-vs-Obese |
5.915000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.334200E-01 |
| Extreme_Weight-vs-Obese |
5.637200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.142600E-01 |
| Obese-vs-Extreme_Obese |
6.949800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.377970E-02 |
| Normal-vs-Age(41-60Yrs) |
3.789900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.423780E-03 |
| Normal-vs-Age(81-100Yrs) |
1.415820E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.096200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.958000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.488600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.742190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.542200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.659000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.693710E-02 |
| Normal-VS-Type2 PRCC |
5.90069999999443E-05 |
| Normal-VS-KIRP CIMP |
5.256500E-03 |
| Normal-VS-Unclassified PRCC |
1.205380E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.281100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.332380E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.716600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.645400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.010830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.303800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.85970000030767E-07 |
| Normal-vs-N1 |
2.001800E-03 |
| Normal-vs-N2 |
2.657100E-03 |
| N0-vs-N1 |
6.745800E-01 |
| N0-vs-N2 |
4.874800E-01 |
| N1-vs-N2 |
4.776400E-01 |
|
|
